Clinical Trials
All Clinical Trials - Page 53 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01786915Phase 1Completed
Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days
Elamipretide
- NCT01798836Phase 2/Phase 3Terminated
Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF
Gonadorelin
- NCT01733758Phase 3Completed
A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
Liraglutide
- NCT01856790EARLY_Phase 1Completed
Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
Liraglutide
- NCT01790308Phase 4Unknown
Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
Liraglutide
- NCT02201550N/ACompleted
Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide
Liraglutide
- NCT01789086Phase 1Completed
A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
Liraglutide
- NCT02349802Phase 1Completed
Autoinjector Device Assessment Study
Exenatide
- NCT01794429Phase 3Completed
Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
Exenatide
- NCT01652729Phase 3Completed
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT01455909Phase 3Withdrawn
A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes
Exenatide
- NCT01455922Phase 3Withdrawn
A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes
Exenatide
- NCT01455883Phase 3Withdrawn
A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes
Exenatide
- NCT02010385N/ACompleted
Investigation of the Effects of Obesity Surgery on Appetitive Behaviour
Octreotide
- NCT01707225Phase 1Completed
Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)
Octreotide
- NCT02147470N/AUnknown
Evaluation of Renal Blood Flow Using Contrast Enhanced Ultrasound for Differential Diagnosis of Acute Kidney Injury in Cirrhotic Patients: A Pilot Study
Octreotide
- NCT01796301Phase 3Completed
An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women
Teriparatide
- NCT01749137Phase 2Completed
Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants
Setmelanotide
- NCT01677910Phase 3Completed
TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)
Octreotide
- NCT01731925Phase 2Unknown
A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors
Lanreotide
- NCT03297879Phase 4Completed
Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
Exenatide
- NCT01873378N/ACompleted
GnRH Agonist Pretreatment in Hysteroscopic Myomectomy
Gonadorelin
- NCT01750398Phase 2Completed
Bipolar Androgen-based Therapy for Prostate Cancer (BAT)
Gonadorelin
- NCT01769781Phase 4Completed
Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence
Gonadorelin
- NCT01755416Phase 2Completed
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
Liraglutide
- NCT02113332Phase 2Completed
Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
Liraglutide
- NCT01755572Phase 4Completed
Blood Pressure Outcomes With Liraglutide Therapy
Liraglutide
- NCT01769378Phase 3Completed
Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
Dulaglutide
- NCT01652716Phase 3Completed
Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
Exenatide
- NCT01768559Phase 3Completed
Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
Lixisenatide
- NCT01753856Phase 4Completed
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Teriparatide
- NCT02025179Phase 2Completed
12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
Teriparatide
- NCT01750086Phase 4Completed
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Teriparatide
- NCT01783899N/ACompleted
Clinical Evaluation of Hemospray in Hemostasis of Active Variceal Bleeding
Octreotide
- NCT01729819Phase 2Completed
Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
Desmopressin
- NCT01767090Phase 2Completed
A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain
Gonadorelin
- NCT01766245Phase 1Completed
A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes
Semaglutide
- NCT01746849Phase 2Active Not Recruiting
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
Ghrp-6
- NCT01755858Phase 1/Phase 2Terminated
Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery
Elamipretide
- NCT01664676Phase 4Completed
Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients
Liraglutide
- NCT01753362Phase 3Completed
Liraglutide In Overweight Patients With Type 1 Diabetes
Liraglutide
- NCT01783717N/AUnknown
Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
Exenatide
- NCT01825148N/ACompleted
GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
Exenatide
- NCT01705587Phase 4Completed
Fracture (FX) Improvement With Teriparatide: FiX-IT Study
Teriparatide
- NCT01657162Phase 3Completed
Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis
Abaloparatide
- NCT01747200N/ACompleted
Effects of Transcranial Magnetic Stimulation on Object Recognition
Selank
- NCT01541215Phase 3Completed
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Liraglutide
- NCT01722266Phase 3Completed
Liraglutide in the Treatment of Type 1 Diabetes Mellitus
Liraglutide
- NCT01722240Phase 3Completed
Liraglutide in Type 1 Diabetes
Liraglutide
- NCT01754818Phase 1Completed
A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)
Elamipretide